Legend Biotech Hits New 54-Week High

Biopharmaceutical company Legend BioTech (LEGN) hit a new 54-week high this Tuesday, up 103.4% this year. LEGN is a multinational biopharmaceutical company primarily engaged in the discovery and development of cell therapies for oncology. The company’s current lead project is an antigen...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.